Diabetes and COVID-19: A review / Journal of the ASEAN Federation of Endocrine Societies
Journal of the ASEAN Federation of Endocrine Societies
; : 40-48, 2020.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-961885
Responsible library:
WPRO
ABSTRACT
@#Coronavirus Disease 2019 (COVID-19) is an emerging disease and since its first identification in Wuhan, China, in December 2019, there has been a rapid increase in cases and deaths across the world. COVID-19 has been shown to have an immense impact in infected persons with diabetes, worsening their outcome, especially in elderly, smokers, obese, those having CVD, CKD, poor glycemic control and long duration of diabetes. In this review we summarize the current understanding of `the impact of COVID-19 on diabetes and discusses the pathophysiological mechanisms and management of diabetes and its complication in this scenario.
Search on Google
Health context:
SDG3 - Target 3.3 End transmission of communicable diseases
/
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
Health problem:
COVID-19
/
Pneumonia
/
Diabetes Mellitus
/
Endocrine System Diseases
/
Other Malignant Neoplasms
/
Other Respiratory Diseases
Database:
WPRIM (Western Pacific)
Main subject:
Diabetes Mellitus
/
COVID-19
Language:
English
Journal:
Journal of the ASEAN Federation of Endocrine Societies
Year:
2020
Document type:
Article